Pentosan Polysulfate Sodium and Meclofenamic Acid as Treatments in Patients With Psychotic Disorders
Status:
Completed
Trial end date:
2016-10-06
Target enrollment:
Participant gender:
Summary
This study evaluates the feasibility of administering meclofenamic acid or pentosan
polysulfate sodium as an adjunctive treatment to patients diagnosed with a psychotic
disorder. Half of participants will receive meclofenamic acid, while the other half will
receive polysulfate sodium.
Phase:
Phase 2
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston